Moloney Securities Asset Management, LLC Moderna, Inc. Transaction History
Moloney Securities Asset Management, LLC
- $664 Million
- Q1 2025
A detailed history of Moloney Securities Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 50,150 shares of MRNA stock, worth $1.43 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
50,150
Previous 4,854
933.17%
Holding current value
$1.43 Million
Previous $201,000
606.97%
% of portfolio
0.21%
Previous 0.03%
Shares
25 transactions
Others Institutions Holding MRNA
# of Institutions
917Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.15 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.11 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$730 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$502 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$209 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...